封面
市場調查報告書
商品編碼
2107853

臨床試驗中心網路市場:依治療領域、最終用戶和地區分類

Clinical Investigate Site Network Market, By Therapeutic Areas, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

臨床試驗中心網路市場預計到 2026 年將達到 76.642 億美元,預計到 2033 年將達到 128.508 億美元。預計從 2026 年到 2033 年,其複合年成長率將達到 7.7%。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 76.642億美元
歷史數據時期: 2020年至2024年 預測期: 2026年至2033年
2026年至2033年預測期間的複合年成長率: 7.70% 2033年市場規模預測: 128.508億美元

全球臨床試驗中心網路(CISN)市場是臨床研究基礎設施的重要組成部分,它提供了一個由醫院、大學附屬醫院、獨立研究中心和專業合約研究組織(CRO)組成的系統化網路。 CISN能夠透過加快受試者招募、最佳化施行地點選擇、統一和標準化試驗方案以及確保多個中心符合監管要求,從而簡化多中心試驗流程。

慢性病和罕見疾病的增加、對製藥和生物技術研發投入的加大,以及縮短從藥物發現到最終藥物開發前置作業時間的需求,都在推動市場成長。此外,分散式臨床試驗的普及、更嚴格的監管指南以及數位醫療工具的採用,也提高了臨床試驗中心網路的全球覆蓋範圍和擴充性。

市場動態

全球臨床試驗中心網路市場的發展主要受腫瘤學、罕見疾病和神經病學等治療領域臨床試驗數量和複雜性不斷增加的驅動。此外,製藥和生技公司加大研發投入,以及分散式和混合型臨床試驗的日益普及,也進一步推動了這個市場的發展。

然而,該市場面臨許多限制因素,包括受試者招募延遲、各國監管差異以及熟練的臨床研究專業人員短缺。儘管如此,人工智慧、真實世界數據分析、電子健康記錄 (EHR) 整合和數位化病人參與平台等方面的進步,將為臨床試驗中心網路市場帶來新的成長機會。

本次調查的主要特點

  • 本研究揭示了各個細分市場的潛在商機,並為該市場說明了一個具有吸引力的投資提案矩陣。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數介紹了全球臨床試驗中心網路市場主要參與者的概況:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 這份「全球臨床試驗中心網路市場」報告針對產業內的各種相關人員,包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
  • 相關人員可以透過利用分析全球臨床試驗中心網路市場中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要

第3章:市場動態、監管與趨勢分析

  • 市場動態
  • 影響分析
  • 主要亮點
  • 監管趨勢
  • 產品上市及核准
  • PEST分析
  • 波特的分析
  • 市場機遇
  • 監管趨勢
  • 產業趨勢

第4章 全球臨床試驗中心網路市場:依治療領域分類,2021-2033年

  • 腫瘤學
  • 血液學
  • 感染疾病
  • 其他

第5章 全球臨床試驗中心網路市場:依最終使用者分類,2021-2033年

  • 贊助
  • 受託研究機構(CRO)
  • 其他

第6章 全球臨床試驗中心網路市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 墨西哥
    • 其他拉丁美洲國家
  • 歐洲
    • 德國
    • 英國
    • 西班牙
    • 法國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 韓國
    • ASEAN
    • 其他亞太國家
  • 中東
    • 海灣合作理事會國家
    • 以色列
    • 其他中東國家
  • 非洲
    • 南非
    • 北非
    • 中非

第7章 競爭情勢

  • 公司簡介
    • Elligo Health Research
    • Thermo Fisher Scientific Inc.
    • ICON plc
    • Parexel International Corporation
    • Fortrea Holdings Inc.
    • Medpace Holdings, Inc.
    • Velocity Clinical Research
    • Headlands Research
    • CenExel Clinical Research
    • Alliance for Multispecialty Research, LLC

第8章 分析師建議

  • 機會分析
  • 分析師意見
  • Coherent Opportunity Map

第9章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於本公司
簡介目錄
Product Code: CMI9863

Clinical Investigate Site Network Market is estimated to be valued at USD 7,664.2 Mn in 2026 and is expected to reach USD 12,850.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 7.7% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 7,664.2 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 7.70% 2033 Value Projection: USD 12,850.8 Mn

The global clinical investigative site network market is one component of the clinical research infrastructure, offering a structured group of hospitals, academic medical centers, standalone research centers and specialized contract research organizations (CROs). CISNs can streamline multicenter trials through patient recruitment acceleration, improved selection of trial locations, trial protocols harmonization, standardization and regulatory compliance across multiple sites.

The growth in chronic and rare diseases, increase in investment in the drug and biotechnology R&D, need to reduce turnaround time from drug discovery to development of the end drug are driving the market. Moreover, decentralized trials and the increase in the stringent regulatory guidelines, with the adoption of digital health tools the global reach and the scalable nature of the network of the clinical investigational site are rising across.

Market Dynamics

The global clinical investigate site network market is driven by the increasing number and complexity of clinical trials in therapeutic areas like oncology, rare diseases, and neurology. The increased investment on R&D in pharmaceutical and biotechnology organizations along with an increasing adoption of decentralized and hybrid clinical trials.

However, a number of constraints are present in the market, such patient recruitment delay, regulatory variations among different countries, and shortage of skilled clinical research professional. Nevertheless, advancements in artificial intelligence, real-world data analytics, electronic health record integration, and digital patient engagement platforms will offer new opportunities for growth in clinical investigate site network market.

Key Features of the Study

  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global clinical investigate site network market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Elligo Health Research, Thermo Fisher Scientific Inc., ICON plc, Parexel International Corporation, Fortrea Holdings Inc., Medpace Holdings, Inc., Velocity Clinical Research, Headlands Research, CenExel Clinical Research, and Alliance for Multispecialty Research, LLC
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global clinical investigate site network market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global clinical investigate site network market

Market Segmentation

  • Therapeutic Areas Insights (Revenue, USD Mn, 2021 - 2033)
  • Oncology
  • Hematology
  • Infectious Diseases
  • Others
  • End User Insights (Revenue, USD Mn, 2021 - 2033)
  • Sponsors
  • Contract Research Organizations (CROs)
  • Others
  • Regional Insights (Revenue, USD Mn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
  • Elligo Health Research
  • Thermo Fisher Scientific Inc.
  • ICON plc
  • Parexel International Corporation
  • Fortrea Holdings Inc.
  • Medpace Holdings, Inc.
  • Velocity Clinical Research
  • Headlands Research
  • CenExel Clinical Research
  • Alliance for Multispecialty Research, LLC

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global Clinical Investigate Site Network Market, By Therapeutic Areas
    • Global Clinical Investigate Site Network Market, By End User
    • Global Clinical Investigate Site Network Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Market Opportunities
  • Regulatory Scenario
  • Industry Trends

4. Global Clinical Investigate Site Network Market, By Therapeutic Areas, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Oncology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Hematology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Infectious Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Clinical Investigate Site Network Market, By End User, 2021-2033, (USD Mn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022 - 2033
    • Segment Trends
  • Sponsors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Contract Research Organizations (CROs)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Clinical Investigate Site Network Market, By Region, 2021 - 2033, Value (USD Mn)

  • Introduction
    • Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
    • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Therapeutic Areas, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Therapeutic Areas, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Therapeutic Areas, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Therapeutic Areas, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Therapeutic Areas, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Therapeutic Areas, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
    • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
      • South Africa
      • North Africa
      • Central Africa

7. Competitive Landscape

  • Company Profile
    • Elligo Health Research
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Thermo Fisher Scientific Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • ICON plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Parexel International Corporation
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Fortrea Holdings Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Medpace Holdings, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Velocity Clinical Research
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Headlands Research
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • CenExel Clinical Research
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Alliance for Multispecialty Research, LLC
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies

8. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

9. References and Research Methodology

  • References
  • Research Methodology
  • About us